Upgrade to SI Premium - Free Trial

Camurus (CAMX)

35.94 -0.02 (0.06%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA July 17, 2026 1:23 AM - PR NewsWire Camurus (CAMX) announces expansion of Lilly collaboration, decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal technology June 1, 2026 11:35 AM - StreetInsider Camurus announces expansion of Lilly collaboration June 1, 2026 11:33 AM - PR NewsWire Full Article List